Early-Stage Loss of GALNT6 Predicts Poor Clinical Outcome in Colorectal Cancer

Overview of attention for article published in Frontiers in oncology, May 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 8 X posts from 5 X users, with an upper bound of 13,950 followers.

RT @MSKLibrary: Featured today by @MSKLibrary: Early-Stage Loss of GALNT6 Predicts Poor Clinical Outcome in #ColorectalCancer @MSKPathology…

RT @MSKLibrary: Featured today by @MSKLibrary: Early-Stage Loss of GALNT6 Predicts Poor Clinical Outcome in #ColorectalCancer @MSKPathology…

RT @MSKLibrary: Featured today by @MSKLibrary: Early-Stage Loss of GALNT6 Predicts Poor Clinical Outcome in #ColorectalCancer @MSKPathology…

Featured today by @MSKLibrary: Early-Stage Loss of GALNT6 Predicts Poor Clinical Outcome in #ColorectalCancer @MSKPathology https://t.co/wpyk18aSpG

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.